CLOs on the Move

Beaverton Dental Equipment

www.beavertondental.com

 
Beaverton Dental Equipment is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Prairie Senior Cottages

Prairie Senior Cottages is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Automotive Innovations Inc

Automotive Innovations Inc is a Bridgewater, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ClinX

Clin-X, comprised of three affiliated companies (ClinEdge, BTC Network, and GuideStar Research), provides a full range of clinical and outsourced business services to clinical research institutions, hospitals, pharmaceutical companies, and CROs. Combined, the companies represent four business segments: two global networks of research clinics, consulting and financial management, and patient recruitment and retention. The business segments seamlessly work together to streamline research operations, minimize enrollment timelines, and overall help research institution businesses thrive.

PetDx

PetDx® – The Liquid Biopsy Company for Pets™ is a molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III